-
EP3426264
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3426264
| EP3426264 - IMMUNO-GENE COMBINATION THERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.07.2020 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 14.12.2018 | ||
| Former | The international publication has been made Status updated on 15.09.2017 | Most recent event Tooltip | 30.07.2021 | Change - applicant | published on 01.09.2021 [2021/35] | Applicant(s) | For all designated states The Trustees of the University of Pennsylvania 3401 Walnut Street Philadelphia, PA 19104 / US | [2021/35] |
| Former [2019/03] | For all designated states The University of Pennsylvania 3401 Walnut Street Philadelphia, PA 19104 / US | Inventor(s) | 01 /
STERMAN, Daniel The University of Pennsylvania School of Medicine 3401 Walnut Street Philadelphia, PA 19104 / US | 02 /
ALBEDA, Steven The University of Pennsylvania School of Medicine 3401 Walnut Street Philadelphia, PA 19104 / US | [2019/03] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2019/03] | Griffin, Philippa Jane, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 17763811.1 | 06.03.2017 | [2019/03] | WO2017US20856 | Priority number, date | US201662304233P | 06.03.2016 Original published format: US 201662304233 P | [2019/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017155846 | Date: | 14.09.2017 | Language: | EN | [2017/37] | Type: | A1 Application with search report | No.: | EP3426264 | Date: | 16.01.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.09.2017 takes the place of the publication of the European patent application. | [2019/03] | Search report(s) | International search report - published on: | US | 14.09.2017 | (Supplementary) European search report - dispatched on: | EP | 22.07.2019 | Classification | IPC: | A61K35/14, A61K39/00, A61K39/395, A61K45/06, A61K48/00, A61P35/00 | [2019/34] | CPC: |
A61K31/519 (EP,US);
A61K31/415 (EP,US);
A61K31/555 (EP,US);
A61K31/635 (EP,US);
A61K31/7068 (EP,US);
A61K33/243 (EP,US);
A61K35/761 (EP,US);
A61K38/21 (EP,US);
A61K38/212 (EP,US);
A61K39/12 (US);
A61K39/3955 (US);
A61K45/06 (EP,US);
A61K9/0019 (US);
A61P35/00 (EP,US);
C07K14/4703 (EP,US);
| C-Set: |
A61K31/415, A61K2300/00 (EP,US);
A61K31/519, A61K2300/00 (EP,US);
A61K31/555, A61K2300/00 (US,EP);
A61K31/635, A61K2300/00 (US,EP); |
| Former IPC [2019/03] | A61K35/14, A61K39/00, A61K39/395, A61K45/06, A61K48/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/03] | Title | German: | IMMUNOGENE KOMBINATIONSTHERAPIE | [2019/03] | English: | IMMUNO-GENE COMBINATION THERAPY | [2019/03] | French: | THÉRAPIE D'ASSOCIATION IMMUNOGÉNIQUE | [2019/03] | Entry into regional phase | 02.10.2018 | National basic fee paid | 02.10.2018 | Search fee paid | 02.10.2018 | Designation fee(s) paid | 02.10.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 02.10.2018 | Examination requested [2019/03] | 03.05.2019 | Amendment by applicant (claims and/or description) | 19.02.2020 | Application deemed to be withdrawn, date of legal effect [2020/33] | 06.03.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2020/33] | Request for re-establishment of rights: | 23.09.2020 | Date of receipt | Fees paid | Renewal fee | 27.03.2019 | Renewal fee patent year 03 | 25.02.2020 | Renewal fee patent year 04 | 29.03.2021 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2015002861 (FKD HOLDING OY [FI], et al) [Y] 1-15 * the whole document *; | [Y] - M COLLEONI ET AL, "Pleurectomy, intrapleural cisplatin and interferon followed by systemic carboplatin plus interferon in malignant pleural mesothelioma", ONCOLOGY REPORTS, (19960901), vol. 3, no. 5, doi:10.3892/or.3.5.871, ISSN 1021-335X, pages 871 - 873, XP055603225 [Y] 1-15 * abstract * * page 873 * DOI: http://dx.doi.org/10.3892/or.3.5.871 | International search | [Y]WO2007113648 (PFIZER PROD INC [US], et al) [Y] 1-11 * entire document *; | [A]US2011014644 (SUCHY SARAH L [US], et al) [A] 1-11* entire document *; | [Y]US2014017202 (PARKER NIGEL [GB], et al) [Y] 1-11 * entire document *; | [A] - HANAUSKE et al., "Pemetrexed Disodium: A Novel Antifolate Clinically Active Against Multiple Solid Tumors", The Oncologist, (20010830), vol. 6, no. 4, pages 363 - 373, XP008005751 [A] 1-11 * . entire document. * DOI: http://dx.doi.org/10.1634/theoncologist.6-4-363 | [A] - STERMAN et al., "A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-beta Gene Transfer for Mesothelioma and Metastatic Pleural Effusions", Mol Ther., (20100112), vol. 18, no. Iss. 4, pages 852 - 860, XP055077966 [A] 1-11 * . entire document. * DOI: http://dx.doi.org/10.1038/mt.2009.309 |